Tracking the emergence of high affinity aptamers for rhVEGF165 during capillary electrophoresis-systematic evolution of ligands by exponential enrichment using high throughput sequencing.

Capillary electrophoresis-systematic evolution of ligands by exponential enrichment (CE-SELEX) is a powerful technique for isolating aptamers for various targets, from large proteins to small peptides with molecular weights of several kilodaltons. One of the unique characteristics of CE-SELEX is the relatively high heterogeneity of the ssDNA pools that remains even after multiple rounds of selection. Enriched sequences or highly abundant oligonucleotide motifs are rarely reported in CE-SELEX studies. In this work, we employed 454 pyrosequencing to profile the evolution of an oligonucleotide pool through multiple rounds of CE-SELEX selection against the target recombinant human vascular endothelial growth factor 165 (rhVEGF165). High throughput sequencing allowed up to 3 × 10(4) sequences to be obtained from each selected pool and compared to the unselected library. Remarkably, the highest abundance contiguous sequence (contig) was only present in 0.8% of sequences even after four rounds of selection. Closer analyses of the most abundant contigs, the top 1000 oligonucleotide fragments, and even the eight original FASTA files showed no evidence of prevailing motifs in the selected pools. The sequencing results also provided insight into why many CE-SELEX selections obtain pools with reduced affinities after many rounds of selection (typically >4). Preferential amplification of a particular short polymerase chain reaction (PCR) product allowed this nonbinding sequence to overtake the pool in later rounds of selection suggesting that further refinement of primer design or amplification optimization is necessary. High affinity aptamers with 10(-8) M dissociation constants for rhVEGF165 were identified. The affinities of the higher abundance contigs were compared with aptamers randomly chosen from the final selection pool using affinity capillary electrophoresis (ACE) and fluorescence polarization (FP). No statistical difference in affinity between the higher abundance contigs and the randomly chosen aptamers was observed, supporting the premise that CE-SELEX selects a uniquely heterogeneous pool of high affinity aptamers.

[1]  Sam F. Y. Li,et al.  Selection of aptamers for signal transduction proteins by capillary electrophoresis , 2010, Electrophoresis.

[2]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[3]  Weihong Tan,et al.  Selection of DNA ligands for protein kinase C-delta. , 2006, Chemical communications.

[4]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[5]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[6]  Seung Soo Oh,et al.  Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing , 2010, Proceedings of the National Academy of Sciences.

[7]  Ruth Ann Luna,et al.  Metagenomic pyrosequencing and microbial identification. , 2009, Clinical chemistry.

[8]  Ashok Mulchandani,et al.  Nano aptasensor for protective antigen toxin of anthrax. , 2010, Analytical chemistry.

[9]  Koji Sode,et al.  Screening and Improvement of an Anti-VEGF DNA Aptamer , 2010, Molecules.

[10]  M. Bowser,et al.  In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. , 2004, Analytical chemistry.

[11]  Doris Chen,et al.  Monitoring Genomic Sequences during SELEX Using High-Throughput Sequencing: Neutral SELEX , 2010, PloS one.

[12]  Christopher M Rose,et al.  Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragment. , 2010, The Analyst.

[13]  Hanlee P. Ji,et al.  Next-generation DNA sequencing , 2008, Nature Biotechnology.

[14]  B. Sullenger,et al.  Aptamers: an emerging class of therapeutics. , 2005, Annual review of medicine.

[15]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[16]  Christy F Landes,et al.  Dynamics of an anti-VEGF DNA aptamer: a single-molecule study. , 2008, Biochemical and biophysical research communications.

[17]  M. Bowser,et al.  In vitro evolution of functional DNA using capillary electrophoresis. , 2004, Journal of the American Chemical Society.

[18]  C. Tuerk,et al.  SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis. , 1991, Journal of molecular biology.

[19]  John C Chaput,et al.  Evolution of a histone H4-K16 acetyl-specific DNA aptamer. , 2009, Journal of the American Chemical Society.

[20]  Wilfred W. Li,et al.  MEME: discovering and analyzing DNA and protein sequence motifs , 2006, Nucleic Acids Res..

[21]  L. Gold,et al.  High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. , 1995, Biochemistry.

[22]  N. Janjić,et al.  Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. , 1994, Biochemistry.

[23]  Howard A. Levine,et al.  A mathematical analysis of SELEX , 2007, Comput. Biol. Chem..

[24]  Meng Jing,et al.  Methods for measuring aptamer-protein equilibria: a review. , 2011, Analytica chimica acta.

[25]  David J. Galas,et al.  A Mathematical Analysis ofin VitroMolecular Selection – Amplification , 1996 .

[26]  Koji Sode,et al.  Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method , 2008, Biotechnology Letters.

[27]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[28]  M. Ronaghi.  Pyrosequencing sheds light on DNA sequencing. , 2001, Genome research.

[29]  J. Kinet,et al.  High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. , 1996, Journal of immunology.

[30]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[31]  John C Chaput,et al.  In vitro selection of histone H4 aptamers for recognition imaging microscopy. , 2007, Journal of the American Chemical Society.

[32]  M. Mascini,et al.  Analytical applications of aptamers. , 2005, Biosensors & bioelectronics.

[33]  Weihong Tan,et al.  In vitro Selection of DNA Aptamers to Glioblastoma Multiforme. , 2011, ACS chemical neuroscience.

[34]  M. Metzker.  Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.

[35]  Jijun Tang,et al.  The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods , 2006, Electrophoresis.

[36]  Huanming Yang,et al.  De novo assembly of human genomes with massively parallel short read sequencing. , 2010, Genome research.

[37]  Michael Famulok,et al.  A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y* , 2002, The Journal of Biological Chemistry.

[38]  M. Bowser,et al.  In vitro selection of aptamers with affinity for neuropeptide Y using capillary electrophoresis. , 2005, Journal of the American Chemical Society.

[39]  Michael Musheev,et al.  Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. , 2005, Journal of the American Chemical Society.

[40]  Susan M. Huse,et al.  Accuracy and quality of massively parallel DNA pyrosequencing , 2007, Genome Biology.

[41]  Anirvan M. Sengupta,et al.  Quantitative modeling and data analysis of SELEX experiments , 2005, Physical biology.

[42]  M. Bowser,et al.  Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. , 2005, Analytical chemistry.

[43]  J. Herron,et al.  Use of synthetic peptides as tracer antigens in fluorescence polarization immunoassays of high molecular weight analytes. , 1993, Analytical chemistry.

[44]  Sheela M. Waugh,et al.  2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.

[45]  M. Kan,et al.  Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Rodrigo Lopez,et al.  Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..

[47]  Anthony D. Keefe,et al.  Direct in vitro selection of a 2'-O-methyl aptamer to VEGF. , 2005, Chemistry & biology.

[48]  S. Ranade,et al.  Stem cell transcriptome profiling via massive-scale mRNA sequencing , 2008, Nature Methods.

[49]  George W. Jackson,et al.  Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor , 2009, Biopolymers.